Algert Global LLC Buys 49,230 Shares of Proto Labs, Inc. $PRLB

Key Points

• Algert Global LLC increased its ownership in Proto Labs, Inc. by 137.3% during the first quarter, bringing their total shares to 85,084 with a value of $2.98 million.
• Proto Labs reported earnings of $0.41 EPS in its latest quarter, exceeding analyst expectations of $0.33 EPS, with revenue up 7.6% year-over-year to $135.06 million.
• Analysts have raised ratings on Proto Labs, with Craig Hallum and Cantor Fitzgerald both issuing "buy" ratings and price targets of $54.00 and $51.00, respectively.

Algert Global LLC raised its stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 137.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,084 shares of the industrial products company's stock after buying an additional 49,230 shares during the period. Algert Global LLC owned 0.36% of Proto Labs worth $2,981,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in PRLB. First Trust Advisors LP boosted its position in Proto Labs by 71.9% in the fourth quarter. First Trust Advisors LP now owns 738,576 shares of the industrial products company's stock valued at $28,871,000 after buying an additional 308,970 shares in the last quarter. Pacer Advisors Inc. boosted its position in Proto Labs by 9,033.1% in the first quarter. Pacer Advisors Inc. now owns 148,595 shares of the industrial products company's stock valued at $5,207,000 after buying an additional 146,968 shares in the last quarter. Nuveen LLC acquired a new stake in Proto Labs in the first quarter valued at approximately $2,458,000. Dimensional Fund Advisors LP boosted its position in Proto Labs by 5.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,300,864 shares of the industrial products company's stock valued at $50,851,000 after buying an additional 68,006 shares in the last quarter. Finally, SG Capital Management LLC acquired a new stake in Proto Labs in the fourth quarter valued at approximately $1,950,000. Institutional investors and hedge funds own 84.54% of the company's stock.

Insiders Place Their Bets

In other news, CEO Suresh Krishna bought 1,725 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $43.51 per share, with a total value of $75,054.75. Following the completion of the purchase, the chief executive officer directly owned 18,021 shares of the company's stock, valued at approximately $784,093.71. This represents a 10.59% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 1.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on PRLB shares. Cantor Fitzgerald raised their target price on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Wall Street Zen raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Finally, Craig Hallum raised shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target for the company in a research note on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Proto Labs presently has an average rating of "Moderate Buy" and an average price target of $52.50.

Proto Labs Price Performance

NYSE PRLB traded down $0.25 during mid-day trading on Tuesday, reaching $50.21. 170,072 shares of the stock were exchanged, compared to its average volume of 205,033. Proto Labs, Inc. has a one year low of $26.34 and a one year high of $51.09. The stock has a 50 day simple moving average of $42.55 and a 200-day simple moving average of $39.36. The stock has a market cap of $1.20 billion, a P/E ratio of 83.69 and a beta of 1.33.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business had revenue of $135.06 million during the quarter, compared to the consensus estimate of $128.05 million. During the same quarter last year, the firm earned $0.38 earnings per share. Proto Labs's quarterly revenue was up 7.6% on a year-over-year basis. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Sell-side analysts anticipate that Proto Labs, Inc. will post 0.81 EPS for the current fiscal year.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.